Medline fire, Impella alert, and a 340B battle
Supply Chain Pulse — 2026-06-19
Medline's 1 million-square-foot Tracy, California distribution center is gone — and while the company says most customer orders have been restored, the incident is a live case study in how fast a single facility loss can ripple across hospital supply chains nationwide. Pair that with an FDA safety alert on Abiomed's Impella introducer kits — eight major bleeding events, three contested patient deaths — and your clinical and procurement teams have two urgent action items before 9 AM. Then there's Eli Lilly quietly pulling 340B discounts, drawing federal intervention demands from the hospital sector. Today is less a news day and more a stress test: resilience, patient safety, and drug pricing pressure all landing at once. If your contingency planning still lives in a binder from 2019, today's the day to dust it off.
Quick Hits
Medline Says Most Customer Orders Restored Following Warehouse Fire
A fire destroyed Medline's 1 million-square-foot distribution center in Tracy, California — one of the company's largest — forcing emergency contingency measures across its distribution network. Medline reports most customer orders have been restored, but the incident exposes just how much volume flows through single-node distribution infrastructure. If Medline is a primary or sole-source supplier in your category mix, now is the time to audit your backup sourcing agreements and on-hand par levels for high-velocity consumables.
Source: Healthcare Purchasing News
Abiomed's Impella Heart Pump Introducer Kits Linked to Leakage Issue in FDA Alert
The FDA has issued a safety alert on Abiomed's Impella heart pump introducer kits after eight reported instances of major bleeding, including three patient deaths — though Abiomed has contested the causal link in those fatalities. The Impella device is widely used in high-acuity cardiac procedures, making this alert relevant to any facility running a structural heart or interventional cardiology program. Supply chain and clinical teams should coordinate immediately on current inventory, pending orders, and whether a hold or enhanced monitoring protocol is warranted while the FDA review proceeds.
Source: Medical Device Network
Lilly Halts 340B Drug Discounts, Triggers Fury from Hospital Sector
Eli Lilly has suspended 340B discounts to hospitals, prompting the hospital sector to formally call on federal authorities to intervene — escalating a long-running standoff between manufacturers and safety-net providers over program compliance. The 340B program is a critical margin lever for qualifying hospitals, and Lilly's move follows similar actions by other major manufacturers testing the program's enforcement limits. Pharmacy and supply chain leaders at covered entities should assess financial exposure from the Lilly pullback and monitor whether federal intervention materializes before adjusting drug budgets.
Boston Scientific Announces $138M Investment in Indiana Medical Distribution Center
Boston Scientific is putting $138 million into a new medical distribution center in Indiana, part of a broader domestic manufacturing and logistics expansion trend among major device makers. For supply chain professionals, domestic distribution investment from large suppliers generally signals improved fill rates, shorter lead times, and reduced exposure to international logistics volatility — all meaningful given ongoing tariff uncertainty. Watch whether this footprint shift influences Boston Scientific's contract terms or GPO pricing structures in the next renewal cycle.
Source: Healthcare Purchasing News
Ascension Accelerates ASC Growth in 10 Markets
Ascension CEO Eduardo Conrado is signaling an aggressive push into ambulatory surgery centers across 10 markets, framing ASC expansion as central to the health system's next phase of deal-making and growth. For supply chain leaders supporting Ascension facilities — or competing health systems watching the shift — this means more demand for ASC-specific product portfolios: smaller pack sizes, procedure-specific kits, and lean inventory models that don't map neatly onto acute care contracts. If your supplier agreements haven't been benchmarked against ASC utilization patterns lately, this trend makes that overdue.
How 'Helium-Free' MRI Scanners Are Reshaping Hospital Capital Plans
Helium-free MRI technology is gaining serious traction with systems like Mayo Clinic exploring the option as a way to expand imaging capacity faster and sidestep the chronic volatility of the global helium supply chain. Traditional MRI installations require thousands of liters of liquid helium — a commodity with a history of supply shocks — making helium-free systems an attractive hedge for facilities planning capital equipment refreshes. If your system has MRI projects in the pipeline, this is worth a direct conversation with your imaging vendor about total cost of ownership, not just sticker price.
Hartford HealthCare Shares Supply Chain Playbook at Tech Summit
Hartford HealthCare, named HPN's 2026 Supply Chain Department of the Year, presented its enterprise-wide approach to leadership, technology integration, and continuous improvement at the Healthcare Supply Chain Tech Summit. The recognition reflects a broader industry push toward treating supply chain as a strategic function rather than a cost center — a shift that's gaining urgency as disruptions like the Medline fire and 340B battles demand real-time decision-making capability. The session takeaways are worth seeking out if your team is benchmarking governance structures or building the case for supply chain investment internally.
Source: Healthcare Purchasing News
Johnson & Johnson Invests Over $1B in Jacksonville Vision Operations
J&J is constructing a major new facility in Jacksonville, Florida, dedicated to ACUVUE contact lens manufacturing as part of its announced $55 billion U.S. investment plan. The move deepens domestic production capacity for one of the world's highest-volume vision care product lines, with potential downstream benefits for distribution reliability and tariff insulation. For health systems and ASCs with vision care or ophthalmology programs, domestic capacity expansion from a key supplier is generally a positive signal for long-term supply stability.
Source: Healthcare Purchasing News
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe